NR1D1 and colitis: SR9009 alleviates DSS-induced colitis and myocardial ischemia-reperfusion in wild-type mice, but fails to do so in REV-ERBα-deficient mice, indicating that the effects of SR9009 are REV-ERBα-dependent 25,36.